The ABPI represents innovative research-based biopharmaceutical companies, large, medium and small, leading an exciting new era of biosciences in the UK.
Our industry, a major contributor to the economy of the UK, brings life-saving and life-enhancing medicines to patients. We represent companies who supply more than 80 per cent of all branded medicines used by the NHS and who are researching and developing the majority of the current medicines pipeline, ensuring that the UK remains at the forefront of helping patients prevent and overcome disease.
Globally our industry is researching and developing more than 7,000 new medicines.
The ABPI is recognised by government as the industry body negotiating on behalf of the branded pharmaceutical industry for statutory consultation requirements including the pricing scheme for medicines in the UK.
About ABPI Vaccine Group
The ABPI Vaccine Group is committed to advocating on behalf of the industry on all aspects of vaccination and the benefits it brings to the health of our nation. The Group aims to work in partnership with the public health community throughout the four nations of the UK to encourage the continued and further success of the national immunisation programmes.
Westminster Flu Day is supported by the following companies:
Notes to Editors
Current Flu Vaccination Policy in England.4
According to the influenza immunisation programme 2015/16, an influenza vaccination should be offered for free to: